(RTTNews) – IDEAYA Biosciences Inc. (IDYA) revealed the rates of an underwritten public offering of typical stock and pre-funded warrants. The business is offering 5 million shares of typical stock and pre-funded warrants to acquire 319,150 shares of typical stock in the offering.
The shares of typical stock are being cost a public offering rate of $23.50 per share, before financing discount rates and commissions, and the pre-funded warrants are being cost a public offering cost of $23.4999 per pre-funded warrant. The workout cost of the pre-funded warrants is $0.0001 per share.
In addition, IDEAYA has actually approved the underwriters a 30-day choice to acquire as much as an extra 797,872 shares of its typical stock at the general public offering cost per share, before financing discount rates and commissions.
The aggregate gross earnings to IDEAYA from the offering are anticipated to be about $125 million, before subtracting underwriting discount rates and commissions and other offering costs, and omitting the workout of any pre-funded warrants. The offering is anticipated to close on or about October 27, 2023.
IDYA closed Tuesday's routine market trading at $27.25 up $0.56 or 2.10%. In the after-hours trade, the stock dropped $2.27 or 8.33%.
The views and viewpoints revealed herein are the views and viewpoints of the author and do not always show those of Nasdaq, Inc.
